United States CRDMO Market Size Set to Surpass USD 61.3 Billion by 2031

Published | 13 June 2025

United States CRDMO (Contract Research, Development, and Manufacturing Organization) Market is flourishing, primarily due to a rising demand for impactful biologics to treat various diseases and complex biopharma manufacturing processes.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated United States CRDMO (Contract Research, Development, and Manufacturing Organization) Market size by value at USD 42.72 billion in 2024. During the forecast period between 2025 and 2031, BlueWeave expects United States CRDMO Market size to boom at a significant CAGR of 5.3% reaching a value of USD 61.33 billion by 2031. A prominent driver of United States CRDMO Market is the rising number of chronic diseases due to population growth, Western lifestyle adoption, and economic development. Pharmaceutical companies are increasingly developing effective medical products to speed up treatment due to the increase in chronic diseases among the rapidly aging global population.

Opportunity – Investments in Continuous Manufacturing Technology

Investments in continuous manufacturing technology present a significant growth opportunity for the players in United States CRDMO Market, offering transformative benefits across efficiency, cost, quality, and supply chain resilience. Continuous manufacturing (CM) replaces traditional batch processes with an uninterrupted production flow, enabling real-time monitoring, automation, and rapid process adjustments. This approach drastically reduces manufacturing cycle times, minimizes human error, and enhances product consistency and quality-key advantages for pharmaceutical and biopharmaceutical companies seeking to accelerate drug development and commercialization. In December 2024, BioCentriq, a leading cell therapy CDMO, signed a long-term lease agreement with National Business Parks for developing a cutting-edge manufacturing facility in Princeton, New Jersey. The facility will also serve as the company’s new headquarters with an immediate USD 12 million investment for upgrading the facility with digital advancements.

Sample Request: https://www.blueweaveconsulting.com/report/united-states-crdmo-market/report-sample

API Manufacturing Segment Dominates United States CRDMO Market

The active pharmaceutical ingredient (API) manufacturing segment holds a significant market share in United States CRDMO Market, particularly both small molecule and biologic drug development, as well as the increasing complexity and regulatory requirements associated with their production. Additionally, the commercial manufacturing workflow holds the largest share, reflecting strong demand for large-scale drug production to meet the needs of both domestic and global markets. In terms of therapeutic application, oncology stands out as the leading segment, driven by the high prevalence of cancer and significant investments in new cancer therapies.

Impact of Escalating Geopolitical Tensions on United States CRDMO Market

Intensifying geopolitical tensions among countries across the regions are reshaping United States CRDMO Market through being pushed to reduce their reliance on Chinese CDMOs for critical raw materials and manufacturing services. Legislative actions like the proposed BIOSECURE Act and the threat of higher tariffs on Chinese imports are prompting a strategic shift toward reshoring or diversifying supply chains, often favoring domestic or allied international partners, such as those in South Korea and India. In the short term, these changes may lead to supply disruptions or drug shortages as new suppliers are qualified and integrated.

Competitive Landscape

Major players operating in United States CRDMO Market include Pfizer Centreone, Sai Life Sciences, Icosagen, WuXi Biologics, WuXi AppTec, Esco Aster, Jubilant Biosys, Syngene International, Chemveda, Ardena Holding, BioCentriq, Eurofins, and Jiangsu HUAYI Technology Co., Ltd. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Don’t miss the business opportunity of the United States CRDMO Market. Consult our analysts to gain crucial insights and facilitate your business growth.

The report's in-depth analysis provides information about growth potential, upcoming trends, and United States CRDMO Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in United States CRDMO Market along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

Scope of the Report

About Us

BlueWeave Consulting provides all-inclusive Market Intelligence (MI) Solutions to businesses regarding various products and services online & offline. We offer comprehensive market research reports by analyzing qualitative and quantitative data to boost your business solution's performance. BlueWeave Consulting has built its reputation from scratch by delivering quality inputs and nourishing long-lasting relationships with its clients. We are a promising digital MI solutions company providing agile assistance to make your business endeavors successful.

Contact Us:

BlueWeave Consulting & Research Pvt Ltd

+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662

info@blueweaveconsulting.com